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B-cell lymphoma/leukemia-2 (bcl-2) genes are overexpressed in many cancers. These 
genes increase cell survival by blocking apoptosis, or programmed cell death. The 
objective of this study was to evaluate radiolabeled peptide nucleic acid (PNA)-peptide 
blocking agents, in order to reduce kidney uptake while improving targeting and imaging 
of bcl-2 gene expression by single photon emission computed tomography (SPECT). 
Three blocking agents, lysine, unmodified anti-bcl-2 PNA, and non-radioactive anti-bcl-2 
PNA-peptide conjugate, were evaluated in human HEK293 kidney cells and Mec-1 
chronic lymphocytic leukemia cells. SCID mice bearing Mec-1 tumors were imaged by 
microSPECT/CT after administration of an 111In-labeled, targeted anti-bcl-2 PNA-
peptide conjugate, with and without treatment using the three blocking agents. By using 
radiolabeled peptide nucleic acids, imaging of bcl-2 expression has the potential to 
recognize early molecular events associated with cancer recurrence and treatment 
failure.
 
